Cargando…

Completed absorption of coronavirus disease 2019 (COVID-19) pneumonia lesions: a preliminary study

Background: Complete absorption of coronavirus disease 2019 (COVID-19) pneumonia in a short term was not detailedly reported. We aimed to investigate the clinical and imaging characteristics of COVID-19 patients with complete absorption of pulmonary lesions. Methods: Retrospectively collected the cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xue-yan, Lv, Fa-jin, Lv, Sheng-xiu, Fu, Bin-jie, MD, Wang-jia Li, Ouyang, Yu, Chu, Zhi-gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100646/
https://www.ncbi.nlm.nih.gov/pubmed/33967608
http://dx.doi.org/10.7150/ijms.54675
_version_ 1783688832350158848
author Liu, Xue-yan
Lv, Fa-jin
Lv, Sheng-xiu
Fu, Bin-jie
MD, Wang-jia Li
Ouyang, Yu
Chu, Zhi-gang
author_facet Liu, Xue-yan
Lv, Fa-jin
Lv, Sheng-xiu
Fu, Bin-jie
MD, Wang-jia Li
Ouyang, Yu
Chu, Zhi-gang
author_sort Liu, Xue-yan
collection PubMed
description Background: Complete absorption of coronavirus disease 2019 (COVID-19) pneumonia in a short term was not detailedly reported. We aimed to investigate the clinical and imaging characteristics of COVID-19 patients with complete absorption of pulmonary lesions. Methods: Retrospectively collected the clinical and chest CT data of 224 patients with COVID-19 in one regional medical center. Currently, pulmonary lesions in 37 patients were completely absorbed. The clinical manifestations, laboratory examinations, and CT findings of lesions for these patients were summarized. Results: Among the 37 patients (age, 39.0 ± 12.4 [14-63] years, 20 males), disease in 36 (97.3%) was mild and in 1 (2.7%) was from severe to mild. The most common symptoms were cough (24/37, 64.9%) and fever (23/37, 62.2%). Their laboratory indicators at admission were usually normal, while the white blood cell and neutrophil count significantly increased at discharge (p = 0.004, p = 0.006). On initial CT images, all patients had various pulmonary lesions (mean involved lobes: 2.8 ± 1.5, range: 1-5; mean involved segments: 6.6 ± 4.3, range: 1-16), which mainly manifested as multiple patchy and or spherical ground glass opacities (GGOs) (30/37, 81.1%) with fibrous strips (19/30, 63.3%) or consolidation (11/30, 36.7%). After treatment, lesions in most (33/37, 89.2%) patients were continuously absorbed. At discharge, previous lesions were mostly absorbed in 11 patients (11/37, 29.7%), the main residues were GGOs (24/37, 64.9%), followed by fibrous strips (13/37, 35.1%). On the latest CT, all the pulmonary lesions were completely absorbed, the duration of lesions was 31.6 ± 11.4 days (range: 5-50 days). Conclusion: The pulmonary lesions in some mild COVID-19 patients (generally with normal laboratory indicators at admission, GGOs as the main manifestation on initial CT, and representation of continuous absorption after treatment) could be completely absorbed with a mean duration of 31.6 days.
format Online
Article
Text
id pubmed-8100646
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-81006462021-05-06 Completed absorption of coronavirus disease 2019 (COVID-19) pneumonia lesions: a preliminary study Liu, Xue-yan Lv, Fa-jin Lv, Sheng-xiu Fu, Bin-jie MD, Wang-jia Li Ouyang, Yu Chu, Zhi-gang Int J Med Sci Research Paper Background: Complete absorption of coronavirus disease 2019 (COVID-19) pneumonia in a short term was not detailedly reported. We aimed to investigate the clinical and imaging characteristics of COVID-19 patients with complete absorption of pulmonary lesions. Methods: Retrospectively collected the clinical and chest CT data of 224 patients with COVID-19 in one regional medical center. Currently, pulmonary lesions in 37 patients were completely absorbed. The clinical manifestations, laboratory examinations, and CT findings of lesions for these patients were summarized. Results: Among the 37 patients (age, 39.0 ± 12.4 [14-63] years, 20 males), disease in 36 (97.3%) was mild and in 1 (2.7%) was from severe to mild. The most common symptoms were cough (24/37, 64.9%) and fever (23/37, 62.2%). Their laboratory indicators at admission were usually normal, while the white blood cell and neutrophil count significantly increased at discharge (p = 0.004, p = 0.006). On initial CT images, all patients had various pulmonary lesions (mean involved lobes: 2.8 ± 1.5, range: 1-5; mean involved segments: 6.6 ± 4.3, range: 1-16), which mainly manifested as multiple patchy and or spherical ground glass opacities (GGOs) (30/37, 81.1%) with fibrous strips (19/30, 63.3%) or consolidation (11/30, 36.7%). After treatment, lesions in most (33/37, 89.2%) patients were continuously absorbed. At discharge, previous lesions were mostly absorbed in 11 patients (11/37, 29.7%), the main residues were GGOs (24/37, 64.9%), followed by fibrous strips (13/37, 35.1%). On the latest CT, all the pulmonary lesions were completely absorbed, the duration of lesions was 31.6 ± 11.4 days (range: 5-50 days). Conclusion: The pulmonary lesions in some mild COVID-19 patients (generally with normal laboratory indicators at admission, GGOs as the main manifestation on initial CT, and representation of continuous absorption after treatment) could be completely absorbed with a mean duration of 31.6 days. Ivyspring International Publisher 2021-04-03 /pmc/articles/PMC8100646/ /pubmed/33967608 http://dx.doi.org/10.7150/ijms.54675 Text en © The author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
spellingShingle Research Paper
Liu, Xue-yan
Lv, Fa-jin
Lv, Sheng-xiu
Fu, Bin-jie
MD, Wang-jia Li
Ouyang, Yu
Chu, Zhi-gang
Completed absorption of coronavirus disease 2019 (COVID-19) pneumonia lesions: a preliminary study
title Completed absorption of coronavirus disease 2019 (COVID-19) pneumonia lesions: a preliminary study
title_full Completed absorption of coronavirus disease 2019 (COVID-19) pneumonia lesions: a preliminary study
title_fullStr Completed absorption of coronavirus disease 2019 (COVID-19) pneumonia lesions: a preliminary study
title_full_unstemmed Completed absorption of coronavirus disease 2019 (COVID-19) pneumonia lesions: a preliminary study
title_short Completed absorption of coronavirus disease 2019 (COVID-19) pneumonia lesions: a preliminary study
title_sort completed absorption of coronavirus disease 2019 (covid-19) pneumonia lesions: a preliminary study
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100646/
https://www.ncbi.nlm.nih.gov/pubmed/33967608
http://dx.doi.org/10.7150/ijms.54675
work_keys_str_mv AT liuxueyan completedabsorptionofcoronavirusdisease2019covid19pneumonialesionsapreliminarystudy
AT lvfajin completedabsorptionofcoronavirusdisease2019covid19pneumonialesionsapreliminarystudy
AT lvshengxiu completedabsorptionofcoronavirusdisease2019covid19pneumonialesionsapreliminarystudy
AT fubinjie completedabsorptionofcoronavirusdisease2019covid19pneumonialesionsapreliminarystudy
AT mdwangjiali completedabsorptionofcoronavirusdisease2019covid19pneumonialesionsapreliminarystudy
AT ouyangyu completedabsorptionofcoronavirusdisease2019covid19pneumonialesionsapreliminarystudy
AT chuzhigang completedabsorptionofcoronavirusdisease2019covid19pneumonialesionsapreliminarystudy